Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.10B.
ENTERPRISE VALUE (EV)
$2.10B
Celldex Therapeutics, Inc.
Market Cap
$2.13B
Enterprise Value (EV)
$2.10B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | $2.13B | $2.10B |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | $2.12B |
| Fortrea Holdings Inc. (FTRE)vs › | $2.17B | $3.12B |
| Alvotech (ALVO)vs › | $2.07B | $3.38B |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.05B | $2.30B |
| Azenta, Inc. (AZTA)vs › | $2.04B | $1.91B |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.03B | $1.93B |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.03B | $1.99B |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | $1.90B |
| AxoGen, Inc. (AXGN)vs › | $2.01B | $1.93B |
Market Cap
$2.13B
Total Debt
$0.00
Cash
$28.87M
Enterprise Value
$2.10B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
